Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,405 | 353 | 99.7% |
| Education | $13.94 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $675.42 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $592.06 | 38 | $0 (2024) |
| Amgen Inc. | $585.59 | 67 | $0 (2022) |
| iRhythm Technologies, Inc. | $570.73 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.45 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $300.51 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $290.98 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $275.59 | 17 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $189.60 | 13 | $0 (2024) |
| Abbott Laboratories | $188.85 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,064 | 50 | iRhythm Technologies, Inc. ($428.26) |
| 2023 | $760.92 | 37 | iRhythm Technologies, Inc. ($131.29) |
| 2022 | $206.17 | 20 | Amgen Inc. ($111.17) |
| 2021 | $323.82 | 21 | Amarin Pharma Inc. ($78.65) |
| 2020 | $354.08 | 23 | Janssen Pharmaceuticals, Inc ($82.78) |
| 2019 | $1,134 | 90 | Janssen Pharmaceuticals, Inc ($306.85) |
| 2018 | $699.39 | 58 | Amgen Inc. ($213.58) |
| 2017 | $876.38 | 56 | Abbott Laboratories ($168.45) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Not Applicable | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $31.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $91.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Smith+Nephew, Inc. | PICO (Device), RENASYS TOUCH | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 09/24/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $46.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| Category: Cardiovascular | ||||||
| 08/07/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $87.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,975 | 2,302 | $702,349 | $150,350 |
| 2022 | 28 | 2,122 | 2,540 | $790,020 | $171,408 |
| 2021 | 27 | 2,186 | 2,695 | $857,596 | $187,920 |
| 2020 | 29 | 2,243 | 2,873 | $825,797 | $183,122 |
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 429 | $92,235 | $35,983 | 39.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 132 | 132 | $103,092 | $19,114 | 18.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 303 | 306 | $119,646 | $16,170 | 13.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 111 | $26,307 | $10,073 | 38.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 30 | 30 | $44,100 | $9,914 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $29,232 | $9,371 | 32.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 36 | 36 | $34,164 | $6,217 | 18.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 93 | $15,624 | $5,495 | 35.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 31 | 62 | $12,214 | $5,485 | 44.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 44 | $15,532 | $5,031 | 32.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $16,812 | $4,723 | 28.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 26 | 104 | $28,184 | $4,114 | 14.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 40 | 40 | $29,400 | $2,252 | 7.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 202 | 206 | $17,716 | $1,885 | 10.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 20 | 21 | $11,445 | $1,670 | 14.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 32 | 32 | $17,984 | $1,533 | 8.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $5,040 | $1,516 | 30.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 39 | 39 | $10,803 | $1,506 | 13.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $7,790 | $1,490 | 19.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 69 | 77 | $18,249 | $1,461 | 8.0% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 20 | 20 | $9,500 | $1,424 | 15.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 113 | 125 | $4,500 | $786.97 | 17.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 38 | 38 | $10,526 | $675.64 | 6.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 29 | 29 | $2,291 | $559.06 | 24.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 34 | 35 | $4,060 | $487.56 | 12.0% |
About Dr. Padma Hari, MD
Dr. Padma Hari, MD is a Cardiovascular Disease healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518920545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Padma Hari, MD has received a total of $5,419 in payments from pharmaceutical and medical device companies, with $1,064 received in 2024. These payments were reported across 355 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,405).
As a Medicare-enrolled provider, Hari has provided services to 8,526 Medicare beneficiaries, totaling 10,410 services with total Medicare billing of $692,800. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Raleigh, NC
- Active Since 04/10/2006
- Last Updated 02/25/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518920545
Products in Payments
- XARELTO (Drug) $675.42
- ENTRESTO (Drug) $430.22
- Corlanor (Drug) $364.59
- ZIO XT Patch (Device) $313.56
- LifeVest (Device) $290.98
- ELIQUIS (Drug) $268.90
- Zio monitor (Device) $245.99
- BRILINTA (Drug) $235.37
- MULTAQ (Drug) $227.22
- Repatha (Biological) $221.00
- CAMZYOS (Drug) $187.88
- LEQVIO (Drug) $161.84
- PRADAXA (Drug) $160.16
- NORTHERA (Drug) $149.04
- JARDIANCE (Drug) $140.35
- NEXLETOL (Drug) $128.63
- Vascepa (Drug) $123.65
- Mitra Clip system (Device) $118.70
- VERQUVO (Drug) $118.37
- FARXIGA (Drug) $61.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Raleigh
Dr. Robert Jobe, M.d, M.D
Cardiovascular Disease — Payments: $248,951
Dr. Christopher Kelly, Md, MD
Cardiovascular Disease — Payments: $159,054
James Zidar
Cardiovascular Disease — Payments: $109,038
Dr. Willis Wu, Md, MD
Cardiovascular Disease — Payments: $106,879
Dr. Ashish Patel, M.d, M.D
Cardiovascular Disease — Payments: $91,468
Dr. Sidharth Shah, M.d., M.s, M.D., M.S
Cardiovascular Disease — Payments: $65,244